Instil Bio, Inc.(TIL)

Biotechnology · Dallas, TX

$6.89-0.07 (-0.94%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

EBITDA Yield: N/A

Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The EBITDA yield is N/A as of 2026-10-06T21:03:42.630Z.

Stored calculation inputs

Calculation as of: 2026-10-06T21:03:42.630Z.

Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.

TTM operating EBITDA · period ending 2026-06-30: -35,651,000
Quote market capitalization: 46,693,905
Total debt · period ending 2026-06-30: 3,670,000
Cash · period ending 2026-06-30: 5,541,000

FMP input reference: 1639651ea08d8a43111aa8341d4d68762a5dc33ecadd1da8a92c037613eb041e

EV/EBITDA|Earnings Yield|OCF Yield|FCF Yield|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

TIL EBITDA Yield Metrics

EBITDA YIELD

N/A

TIL Competitors' EBITDA Yield

TIL

Instil Bio, Inc.

Current

Market Cap

$46.69M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CELU

Celularity Inc.

vs TIL

Market Cap

$45.73M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LITS

Lite Strategy, Inc.

vs TIL

Market Cap

$47.98M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

APLM

Apollomics, Inc.

vs TIL

Market Cap

$48.53M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

HOWL

Werewolf Therapeutics, Inc.

vs TIL

Market Cap

$44.72M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SNWV

SANUWAVE Health Inc.

vs TIL

Market Cap

$44.71M

EBITDA Yield

4.14%

TTM Avg

3.76%

3Y Avg

3.51%

5Y Avg

3.51%

MBOT

Microbot Medical Inc.

vs TIL

Market Cap

$48.76M

EBITDA Yield

N/A

TTM Avg

0.89%

3Y Avg

5.54%

5Y Avg

4.70%

TELA

TELA Bio, Inc.

vs TIL

Market Cap

$48.77M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SRTS

Sensus Healthcare, Inc.

vs TIL

Market Cap

$48.89M

EBITDA Yield

N/A

TTM Avg

11.25%

3Y Avg

14.93%

5Y Avg

13.84%

POCI

Precision Optics Corporation, Inc.

vs TIL

Market Cap

$49.25M

EBITDA Yield

N/A

TTM Avg

0.84%

3Y Avg

0.84%

5Y Avg

0.84%

NAME	MARKET CAP	EBITDA YIELD	TTM	3Y	5Y
Instil Bio, Inc. (TIL)	$46.69M	N/A	N/A	N/A	N/A
Celularity Inc. (CELU)vs ›	$45.73M	N/A	N/A	N/A	N/A
Lite Strategy, Inc. (LITS)vs ›	$47.98M	N/A	N/A	N/A	N/A
Apollomics, Inc. (APLM)vs ›	$48.53M	N/A	N/A	N/A	N/A
Werewolf Therapeutics, Inc. (HOWL)vs ›	$44.72M	N/A	N/A	N/A	N/A
SANUWAVE Health Inc. (SNWV)vs ›	$44.71M	4.14%	3.76%	3.51%	3.51%
Microbot Medical Inc. (MBOT)vs ›	$48.76M	N/A	0.89%	5.54%	4.70%
TELA Bio, Inc. (TELA)vs ›	$48.77M	N/A	N/A	N/A	N/A
Sensus Healthcare, Inc. (SRTS)vs ›	$48.89M	N/A	11.25%	14.93%	13.84%
Precision Optics Corporation, Inc. (POCI)vs ›	$49.25M	N/A	0.84%	0.84%	0.84%

EBITDA Yield Formula & Definition

EBITDA Yield = TTM EBITDA / Enterprise Value

EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EBITDA Yield: N/A

TIL EBITDA Yield Metrics

TIL Competitors' EBITDA Yield

EBITDA Yield Formula & Definition

Related Metrics